Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
Saved in:
| Title: | Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. |
|---|---|
| Authors: | Hopcroft, Lorna, Wigmore, Eleanor M., Williamson, Stuart C., Ros, Susana, Eberlein, Cath, Moss, Jennifer I., Urosevic, Jelena, Carnevalli, Larissa S., Talbot, Sara, Bradshaw, Lauren, Blaker, Catherine, Gunda, Sreeharsha, Owenson, Venetia, Hoffmann, Scott, Sutton, Daniel, Jones, Stewart, Goodwin, Richard J. A., Willis, Brandon S., Rooney, Claire, de Bruin, Elza C., et al |
| Source: | NPJ breast cancer 9/19/2023; Vol. 9 (1). |
| Journal Info: | Publisher: Springer Nature ISSN: 2374-4677 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: EPTOC172020146 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hopcroft%2C+Lorna%22">Hopcroft, Lorna</searchLink><br /><searchLink fieldCode="AU" term="%22Wigmore%2C+Eleanor+M%2E%22">Wigmore, Eleanor M.</searchLink><br /><searchLink fieldCode="AU" term="%22Williamson%2C+Stuart+C%2E%22">Williamson, Stuart C.</searchLink><br /><searchLink fieldCode="AU" term="%22Ros%2C+Susana%22">Ros, Susana</searchLink><br /><searchLink fieldCode="AU" term="%22Eberlein%2C+Cath%22">Eberlein, Cath</searchLink><br /><searchLink fieldCode="AU" term="%22Moss%2C+Jennifer+I%2E%22">Moss, Jennifer I.</searchLink><br /><searchLink fieldCode="AU" term="%22Urosevic%2C+Jelena%22">Urosevic, Jelena</searchLink><br /><searchLink fieldCode="AU" term="%22Carnevalli%2C+Larissa+S%2E%22">Carnevalli, Larissa S.</searchLink><br /><searchLink fieldCode="AU" term="%22Talbot%2C+Sara%22">Talbot, Sara</searchLink><br /><searchLink fieldCode="AU" term="%22Bradshaw%2C+Lauren%22">Bradshaw, Lauren</searchLink><br /><searchLink fieldCode="AU" term="%22Blaker%2C+Catherine%22">Blaker, Catherine</searchLink><br /><searchLink fieldCode="AU" term="%22Gunda%2C+Sreeharsha%22">Gunda, Sreeharsha</searchLink><br /><searchLink fieldCode="AU" term="%22Owenson%2C+Venetia%22">Owenson, Venetia</searchLink><br /><searchLink fieldCode="AU" term="%22Hoffmann%2C+Scott%22">Hoffmann, Scott</searchLink><br /><searchLink fieldCode="AU" term="%22Sutton%2C+Daniel%22">Sutton, Daniel</searchLink><br /><searchLink fieldCode="AU" term="%22Jones%2C+Stewart%22">Jones, Stewart</searchLink><br /><searchLink fieldCode="AU" term="%22Goodwin%2C+Richard+J%2E+A%2E%22">Goodwin, Richard J. A.</searchLink><br /><searchLink fieldCode="AU" term="%22Willis%2C+Brandon+S%2E%22">Willis, Brandon S.</searchLink><br /><searchLink fieldCode="AU" term="%22Rooney%2C+Claire%22">Rooney, Claire</searchLink><br /><searchLink fieldCode="AU" term="%22de+Bruin%2C+Elza+C%2E%22">de Bruin, Elza C.</searchLink><br />et al – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> 9/19/2023; Vol. 9 (1). – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>ISSN: </i>2374-4677 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC172020146 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41523-023-00575-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hopcroft, Lorna – PersonEntity: Name: NameFull: Wigmore, Eleanor M. – PersonEntity: Name: NameFull: Williamson, Stuart C. – PersonEntity: Name: NameFull: Ros, Susana – PersonEntity: Name: NameFull: Eberlein, Cath – PersonEntity: Name: NameFull: Moss, Jennifer I. – PersonEntity: Name: NameFull: Urosevic, Jelena – PersonEntity: Name: NameFull: Carnevalli, Larissa S. – PersonEntity: Name: NameFull: Talbot, Sara – PersonEntity: Name: NameFull: Bradshaw, Lauren – PersonEntity: Name: NameFull: Blaker, Catherine – PersonEntity: Name: NameFull: Gunda, Sreeharsha – PersonEntity: Name: NameFull: Owenson, Venetia – PersonEntity: Name: NameFull: Hoffmann, Scott – PersonEntity: Name: NameFull: Sutton, Daniel – PersonEntity: Name: NameFull: Jones, Stewart – PersonEntity: Name: NameFull: Goodwin, Richard J. A. – PersonEntity: Name: NameFull: Willis, Brandon S. – PersonEntity: Name: NameFull: Rooney, Claire – PersonEntity: Name: NameFull: de Bruin, Elza C. IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 09 Text: 9/19/2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2374-4677 Numbering: – Type: volume Value: 9 – Type: issue Value: 1 Titles: – TitleFull: NPJ breast cancer Type: main |
| ResultId | 1 |